NEW YORK, Sept. 15, 2023 /PRNewswire/ — TO: RECORD AND BENEFICIAL HOLDERS OF GW PHARMACEUTICALS, PLC. (“GW”) AMERICAN DEPOSITARY SHARES FROM MARCH 10, 2021 THROUGH AND INCLUDING MAY 5, 2021, THE DATE OF THE CONSUMMATION OF GW’S MERGER WITH JAZZ PHARMACEUTICALS, PLC (THE “MERGER”),…
Monteverde & Associates PC and Kahn Swick & Foti Announce Proposed Class Action Settlement on Behalf of Holders of GW Pharmaceuticals PLC American Depositary Shares
This post was originally published on this site